NasdaqGM - Delayed Quote USD

ProShares Ultra Nasdaq Biotechnology (BIB)

49.66 +0.72 (+1.47%)
At close: April 26 at 4:00 PM EDT

Top 7 Holdings (31.12% of Total Assets)

SymbolCompany% Assets
AMGN
Amgen Inc. 5.91%
GILD
Gilead Sciences, Inc. 5.78%
REGN
Regeneron Pharmaceuticals, Inc. 5.67%
VRTX
Vertex Pharmaceuticals Incorporated 5.65%
MRNA
Moderna, Inc. 2.96%
AZN
AstraZeneca PLC 2.87%
BIIB
Biogen Inc. 2.28%

Sector Weightings

SectorBIB
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 84.74%
Bonds 15.27%

Equity Holdings

Price/Earnings 0
Price/Book 0.27
Price/Sales 0.19
Price/Cashflow 0.06
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 15.27%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

ETF Overview

Category Trading--Leveraged Equity
Fund Family ProShares
Net Assets 96.36M
YTD Daily Total Return -12.89%
Yield 0.14%
Legal Type Exchange Traded Fund

Related Tickers